Diabetes Obes Metab 22(3):355364 Ruiz PLD, Stene LC, Bakken IJ, Hberg SE, Birkeland KI, Gulseth HL (2018) Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study
Healthcare providers typically monitor lipid panels at baseline and after 3-6 months to assess response, with subsequent monitoring individualized based on clinical context
The capsules are easy on the stomach, which is a motivation to keep going with them
A personalized approach can help determine whether peptide therapy may be appropriate
Patients choosing microdose should expect a slower, more subtle experience
Once released, this fat becomes available for energy production